Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Barnes Group, Inc. (NYSE: B).

Full DD Report for B

You must become a subscriber to view this report.


Recent News from (NYSE: B)

Kinnevik: Financial results for the second quarter 2018 for Global Fashion Group
Kinnevik AB (publ) ("Kinnevik") today published financial results for the second quarter 2018 for Global Fashion Group, comprising of the regional businesses Lamoda, Dafiti, Zalora, The Iconic and Namshi. Global Fashion Group will host a conference call today, 7 September 2018, at 10.00 ...
Source: Thomson Reuters ONE
Date: September, 07 2018 02:00
Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group - New Research Emphasizes Economic Growth
NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), BioScrip, Inc. (NASDAQ:BIOS),...
Source: GlobeNewswire
Date: September, 05 2018 07:30
Klövern AB (publ): Klövern acquires shares in Tobin Properties from Erik Karlin and Johan Varland
Klövern AB (publ) has today, through the subsidiary Dagon Sverige AB signed a contract with Erik Karlin, departing CEO in the subsidiary Tobin Properties AB, and with Johan Varland, board member and head of transactions of Tobin Properties, to acquire their respective shareholdings in To...
Source: Thomson Reuters ONE
Date: September, 03 2018 05:30
Klövern AB (publ): Number of shares in Klövern as of 31 August 2018
After conversion of 728,748 Class A ordinary shares to Class B ordinary shares during the month of August the total number of shares in Klövern as of 31 August 2018 amounts to 932,437,980, of which 73,660,263 constitute Class A ordinary shares, 842,333,717 constitute Class B ordinary sha...
Source: Thomson Reuters ONE
Date: August, 31 2018 06:00
ALK submits registration application for tree SLIT-tablet in Europe
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that the European regulatory filing for its investigational tree pollen sublingual allergy immunotherapy (SLIT) tablet has been accepted for review by the relevant health authorities via the decentralised procedure, with Germany a...
Source: GlobeNewswire
Date: August, 22 2018 06:17
Oral semaglutide provides superior HbA1c and weight reductions versus placebo in people with type 2 diabetes and renal impairment in the PIONEER 5 trial
Bagsværd, Denmark, 20 August 2018 - Novo Nordisk today announced the headline results from PIONEER 5, a phase 3a trial with oral semaglutide in adults with type 2 diabetes and moderate renal impairment. Oral semaglutide is an investigational GLP-1 analogue taken once daily as a tablet....
Source: Thomson Reuters ONE
Date: August, 20 2018 04:56
Boeing leads aerospace, defense names higher amid UBS upbeat outlook
Boeing ( BA +4.4% ) is more than 4% higher, responsible for ~100 points of the DJIA's 400-plus point surge today, after UBS analyst Myles Walton praised the stock as part of an upbeat assessment of the broader aerospace and defense sector, which he believes can support 5%-plus organic ...
Source: SeekingAlpha
Date: August, 16 2018 15:43
Kinnevik invests in Kolonial.no - the leading online grocery store in Norway
Kinnevik AB (publ) ("Kinnevik") today announced that it has invested NOK 300m in Kolonial.no AS for a 15% stake in the Norwegian online grocery retailer. Kinnevik invested NOK 200m in primary capital and a further NOK 100m in secondary shares. Kolonial.no was founded in 2013 and offers g...
Source: Thomson Reuters ONE
Date: August, 15 2018 07:05
Six-month interim report (Q2) 2018
Better than expected performance in Q2 (unaudited) ALK’s financial performance in Q2 was better than expected and full-year outlook has been improved. The execution of ALK’s new growth strategy is on track, with good progress being made on the commercialisation of SLIT-table...
Source: GlobeNewswire
Date: August, 14 2018 21:37
Kinnevik: Nomination Committee ahead of the 2019 Annual General Meeting
In accordance with the resolution of the 2018 Annual General Meeting in Kinnevik AB (publ) ("Kinnevik"), Cristina Stenbeck has convened a Nomination Committee comprising representatives of Kinnevik's largest shareholders in terms of voting interest. The Nomination Committee comprises Cris...
Source: Thomson Reuters ONE
Date: August, 08 2018 02:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0867.9268.0368.2967.57151,290
2018-05-1760.1560.7560.8160.08318,630
2017-11-0765.8064.1466.1564.05319,866
2017-11-0666.7165.8866.7365.85307,430
2017-11-0365.7966.5066.5265.77242,305

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-131553,6654.2292Cover
2018-12-1221762534.7200Cover
2018-12-112464,7345.1965Cover
2018-12-101,8815,79532.4590Cover
2018-12-075751,95329.4419Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on B.


About Barnes Group, Inc. (NYSE: B)

Logo for Barnes Group, Inc. (NYSE: B)

Not available

 

Contact Information

 

 

Current Management

  • Edmund M. Carpenter / President, CEO
  • Signe S. Gates / Secretary

Current Share Structure

  • Market Cap: $3,096,048,889 - 05/11/2018
  • Issue and Outstanding: 52,591,284 - 04/25/2018

 


Recent Filings from (NYSE: B)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 27 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 23 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 23 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 16 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 13 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2018

 

 


Daily Technical Chart for (NYSE: B)

Daily Technical Chart for (NYSE: B)


Stay tuned for daily updates and more on (NYSE: B)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: B)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in B is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of B and does not buy, sell, or trade any shares of B. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/